Case ID : Med476
Age : 43 years
Sex : Male
Country : India
Diagnosis : A Quadriparesis patient with Spinal Cord Injury (C6/C7).
The patient was diagnosed back in 2008 with reducible atlantoaxial dislocation with myelomalacia spinal cord because of the trauma 12 years ago. The patient underwent Spinal Cord Decompression surgery and the spine was stabilized. This treatment was not successful and the patient becomes completely paralyzed from neck till down.
Reason to choose MedAcess, India for Stem Cell Treatment :
The patient has tried all the available conventional treatment methods along with the surgery in his home country as well abroad however, he found no improvements after the cessation of his natural recovery. He thought of trying new treatment options and contacted MedAcess, India for further treatment.
Date of treatment : 29th Dec 2016
Treatment Place : Facility of MedAcess, India
Pre-Treatment condition :
- Residual Neurological Deficit persisted
- He required a walker.
- There was no control in bladder above 5-6 hours.
- There was no spasticity in all muscles.
Treatment performed in MedAcess, India :
- Mesenchymal Stem Cells derived from Wharton’s Jelly of Human Umbilical Cord.
- The patient was administered total 4 injections of Stem Cells.
- 2 injections through intravenous route with a dose of 1 million stem cells per Kg of the patient's body weight.
- 2 injections of the competent stem cells through Intrathecal route.
- Physiotherapy session.
Post-Treatment condition :
Before the discharge of the patient from the MedAcess facility, the following improvements were noted by our team –
- He experienced more power in his muscles.
- He experienced more control in all muscles.
- His spasticity duration reduced significantly.
- His bladder control improved and now he can hold it up to 8 hours.
- His overall condition improved.
- His general well being is also enhanced.
Disclaimer: Stem Cell Therapy at MedAcess, India does not fall under the realm of approved treatment modalities. The improvements and results out of this therapy may vary from patient to patient depending upon the conditions.
The patient’s name has not been disclosed to protect their identity.